Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Invesco Pharmaceuticals ETF (NY:PJP)

118.79 -1.01 (-0.84%)

Official Closing Price Updated: 8:00 PM EDT, Jul 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	52,996
Open	120.10
Bid (Size)	116.73 (200)
Ask (Size)	179.05 (100)
Prev. Close	119.80
Today's Range	118.65 - 120.11
52wk Range	80.63 - 122.69
Shares Outstanding	28,900
Dividend Yield	0.92%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026? ↗

Today 15:33 EDT

PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking broad sector exposure.

Via The Motley Fool

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026? ↗

July 20, 2026

IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.

Via The Motley Fool

Performance

YTD	+13.8%	+13.8%
1 Month	+5.9%	+5.9%
3 Month	+13.4%	+13.4%
6 Month	+12.4%	+12.4%
1 Year	+42.7%	+42.7%

More News

PJP vs. IYH: Which Healthcare ETF Is the Better Buy? ↗

July 20, 2026

Via The Motley Fool

Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided ↗

July 21, 2025

Via Stocktwits

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗

July 09, 2026

Via The Motley Fool

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? ↗

July 08, 2026

Via The Motley Fool

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors? ↗

July 05, 2026

Via The Motley Fool

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? ↗

July 04, 2026

Via The Motley Fool

State Street Health Care ETF Tops Invesco Pharma on Cost and Size ↗

July 04, 2026

Via The Motley Fool

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? ↗

June 15, 2026

Via The Motley Fool

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗

June 05, 2026

Via The Motley Fool

Why Did CANF Stock Soar 40% In Pre-Market Today? ↗

March 04, 2026

Via Stocktwits

Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗

February 23, 2026

Via Stocktwits

FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗

February 18, 2026

Via Stocktwits

Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗

January 15, 2026

Via Stocktwits

US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗

December 01, 2025

Via Stocktwits

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Via Benzinga

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

Via Benzinga

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗

September 08, 2025

Via Benzinga

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗

August 01, 2025

Via Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗

July 16, 2025

Via Benzinga

FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗

July 11, 2025

Via Stocktwits

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Via Benzinga

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗

June 20, 2025

Via Benzinga

FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗

June 17, 2025

Via Stocktwits

Frequently Asked Questions

Is Invesco Pharmaceuticals ETF publicly traded?

Yes, Invesco Pharmaceuticals ETF is publicly traded.

What exchange does Invesco Pharmaceuticals ETF trade on?

Invesco Pharmaceuticals ETF trades on the New York Stock Exchange

What is the ticker symbol for Invesco Pharmaceuticals ETF?

The ticker symbol for Invesco Pharmaceuticals ETF is PJP on the New York Stock Exchange

What is the current price of Invesco Pharmaceuticals ETF?

The current price of Invesco Pharmaceuticals ETF is 118.79

When was Invesco Pharmaceuticals ETF last traded?

The last trade of Invesco Pharmaceuticals ETF was at 07/22/26 08:00 PM ET

What is the market capitalization of Invesco Pharmaceuticals ETF?

The market capitalization of Invesco Pharmaceuticals ETF is 3.43M

How many shares of Invesco Pharmaceuticals ETF are outstanding?

Invesco Pharmaceuticals ETF has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.